Want to see AU:VBS full AI Analyst Report?
Vectus Biosystems Limited (VBS) Financial Statements
Vectus Biosystems Limited Financial Overview
Vectus Biosystems Limited's market cap is currently $4.66M. The company's EPS TTM is $0.03; its P/E ratio is 2.60; Vectus Biosystems Limited is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 478.18K | $ 1.14M | $ 1.35M | $ 1.30M |
| Gross Profit | $ -4.60K | $ 478.18K | $ 1.14M | $ 1.31M | $ 1.28M |
| Operating Income | $ -1.37M | $ -1.69M | $ -2.27M | $ -4.60M | $ -4.60M |
| EBITDA | $ -1.36M | $ -1.69M | $ -2.27M | $ -3.19M | $ -3.28M |
| Net Income | $ 1.56M | $ -1.78M | $ -2.34M | $ -3.45M | $ -3.99M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.52M | $ 250.99K | $ 808.97K | $ 2.95M | $ 1.28M |
| Total Assets | $ 3.82M | $ 782.66K | $ 2.03M | $ 4.63M | $ 3.94M |
| Total Debt | $ 546.66K | $ 200.00K | $ 28.93K | $ 70.21K | $ 6.90M |
| Net Debt | $ -171.93K | $ -50.99K | $ -780.04K | $ -2.88M | $ 5.62M |
| Total Liabilities | $ 1.50M | $ 1.04M | $ 539.26K | $ 1.11M | $ 8.36M |
| Stockholders' Equity | $ 2.32M | $ -256.62K | $ 1.49M | $ 3.52M | $ -4.42M |
| Cash Flow | |||||
| Free Cash Flow | $ -573.40K | $ -830.09K | $ -2.10M | $ -2.37M | $ -4.46M |
| Operating Cash Flow | $ -573.39K | $ -830.09K | $ -2.03M | $ -2.35M | $ -4.44M |
| Investing Cash Flow | $ 0.00 | $ 101.03K | $ -67.90K | $ -17.13K | $ -21.00K |
| Financing Cash Flow | $ 1.04M | $ 171.07K | $ -41.28K | $ 4.04M | $ -34.55K |
Currency in AUD